| # | Title | Journal | Year | Citations |
|---|
| 1 | Severe Asthma and Biological Therapy: When, Which, and for Whom | Pulmonary Therapy | 2020 | 63 |
| 2 | Identification of Asthma Subtypes Using Clustering Methodologies | Pulmonary Therapy | 2016 | 54 |
| 3 | In-Vitro Characterization of the Aerosolized Dose During Non-Invasive Automatic Continuous Positive Airway Pressure Ventilation | Pulmonary Therapy | 2016 | 54 |
| 4 | A Review on the Safety and Efficacy of Inhaled Corticosteroids in the Management of Asthma | Pulmonary Therapy | 2017 | 53 |
| 5 | Potential Benefit of Repeated Dry Powder Inhaler’s Inhalation Technique Counseling on Asthmatic Patients | Pulmonary Therapy | 2015 | 43 |
| 6 | Diagnosis and Management of Pulmonary Hypertension in the Modern Era: Insights from the 6th World Symposium | Pulmonary Therapy | 2020 | 38 |
| 7 | Effect of Nebulizer Designs on Aerosol Delivery During Non-Invasive Mechanical Ventilation: A Modeling Study of In Vitro Data | Pulmonary Therapy | 2017 | 37 |
| 8 | Digital Inhalers for Asthma or Chronic Obstructive Pulmonary Disease: A Scientific Perspective | Pulmonary Therapy | 2021 | 37 |
| 9 | The Role of the Body Clock in Asthma and COPD: Implication for Treatment | Pulmonary Therapy | 2018 | 36 |
| 10 | 3D Printing and Personalized Airway Stents | Pulmonary Therapy | 2017 | 30 |
| 11 | A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β2-Agonist (LABA) Combinations in COPD | Pulmonary Therapy | 2017 | 30 |
| 12 | Critically Ill Patients with COVID-19: A Narrative Review on Prone Position | Pulmonary Therapy | 2020 | 30 |
| 13 | A Review: Does Complement or the Contact System Have a Role in Protection or Pathogenesis of COVID-19? | Pulmonary Therapy | 2020 | 29 |
| 14 | Machine Learning for Pulmonary and Critical Care Medicine: A Narrative Review | Pulmonary Therapy | 2020 | 28 |
| 15 | Chronic Cough in Adults: Make the Diagnosis and Make a Difference | Pulmonary Therapy | 2019 | 26 |
| 16 | Treatment of Persistent Cough in Subjects with Idiopathic Pulmonary Fibrosis (IPF) with Gefapixant, a P2X3 Antagonist, in a Randomized, Placebo-Controlled Clinical Trial | Pulmonary Therapy | 2021 | 25 |
| 17 | Virtual Multidisciplinary Tumor Boards: A Narrative Review Focused on Lung Cancer | Pulmonary Therapy | 2021 | 25 |
| 18 | The Respimat® Development Story: Patient-Centered Innovation | Pulmonary Therapy | 2017 | 24 |
| 19 | The Role of Palliative Care in Reducing Symptoms and Improving Quality of Life for Patients with Idiopathic Pulmonary Fibrosis: A Review | Pulmonary Therapy | 2020 | 24 |
| 20 | Prevalence and Burden of Dyspnoea Among Patients with Chronic Obstructive Pulmonary Disease in Five European Countries | Pulmonary Therapy | 2016 | 23 |
| 21 | Aerosol Deposition of Inhaled Corticosteroids/Long-Acting β2-Agonists in the Peripheral Airways of Patients with Asthma Using Functional Respiratory Imaging, a Novel Imaging Technology | Pulmonary Therapy | 2017 | 23 |
| 22 | A 2019 Update on Occupational Lung Diseases: A Narrative Review | Pulmonary Therapy | 2021 | 23 |
| 23 | In Vitro Determination of the Main Effects in the Design of High-Flow Nasal Therapy Systems with Respect to Aerosol Performance | Pulmonary Therapy | 2018 | 22 |
| 24 | Real-World Outcomes Among Patients with Cystic Fibrosis Treated with Ivacaftor: 2012–2016 Experience | Pulmonary Therapy | 2020 | 22 |
| 25 | In Vitro Study of the Effect of Breathing Pattern on Aerosol Delivery During High-Flow Nasal Therapy | Pulmonary Therapy | 2019 | 20 |
| 26 | Ex Vivo Lung Perfusion: A Review of Current and Future Application in Lung Transplantation | Pulmonary Therapy | 2022 | 20 |
| 27 | Improving the Efficiency of Respiratory Drug Delivery: A Review of Current Treatment Trends and Future Strategies for Asthma and Chronic Obstructive Pulmonary Disease | Pulmonary Therapy | 2017 | 19 |
| 28 | Identifying Critical Errors: Addressing Inhaler Technique in the Context of Asthma Management | Pulmonary Therapy | 2018 | 19 |
| 29 | Asthma Diagnosis: The Changing Face of Guidelines | Pulmonary Therapy | 2019 | 18 |
| 30 | Management of Pleural Infection | Pulmonary Therapy | 2021 | 18 |
| 31 | Dehydroepiandrosterone Supplementation May Benefit Women with Asthma Who Have Low Androgen Levels: A Pilot Study | Pulmonary Therapy | 2019 | 16 |
| 32 | The Interplay Between Coagulation and Inflammation Pathways in COVID-19-Associated Respiratory Failure: A Narrative Review | Pulmonary Therapy | 2020 | 16 |
| 33 | Triple Therapy of Umeclidinium + Inhaled Corticosteroids/Long-Acting Beta2 Agonists for Patients with COPD: Pooled Results of Randomized Placebo-Controlled Trials | Pulmonary Therapy | 2016 | 15 |
| 34 | Prescribing Pathways to Triple Therapy: A Multi-Country, Retrospective Observational Study of Adult Patients with Chronic Obstructive Pulmonary Disease | Pulmonary Therapy | 2020 | 15 |
| 35 | Physiologically Based Pharmacokinetic Modeling of CFTR Modulation in People with Cystic Fibrosis Transitioning from Mono or Dual Regimens to Triple-Combination Elexacaftor/Tezacaftor/Ivacaftor | Pulmonary Therapy | 2020 | 15 |
| 36 | Budesonide/Formoterol Easyhaler®: Performance Under Simulated Real-Life Conditions | Pulmonary Therapy | 2017 | 14 |
| 37 | Comparison of Phospholipid-Based Particles for Sustained Release of Ciprofloxacin Following Pulmonary Administration to Bronchiectasis Patients | Pulmonary Therapy | 2019 | 14 |
| 38 | Bronchial Artery Embolisation for Massive Haemoptysis: Immediate and Long-Term Outcomes—A Retrospective Study | Pulmonary Therapy | 2020 | 14 |
| 39 | A Comprehensive Review of Sarcoidosis Treatment for Pulmonologists | Pulmonary Therapy | 2021 | 14 |
| 40 | Colobreathe® for the Treatment of Cystic Fibrosis-Associated Pulmonary Infections | Pulmonary Therapy | 2015 | 13 |
| 41 | Volume Management in Pulmonary Arterial Hypertension Patients: An Expert Pulmonary Hypertension Clinician Perspective | Pulmonary Therapy | 2018 | 13 |
| 42 | Umeclidinium/Vilanterol Versus Tiotropium/Olodaterol in Maintenance-Naïve Patients with Moderate Symptomatic Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis | Pulmonary Therapy | 2018 | 12 |
| 43 | Epidemiology of Pulmonary Fibrosis: A Cohort Study Using Healthcare Data in Sweden | Pulmonary Therapy | 2019 | 12 |
| 44 | Mandibular Advancement Devices for OSA: An Alternative to CPAP? | Pulmonary Therapy | 2021 | 12 |
| 45 | A Real-World Study of 30-Day Exacerbation Outcomes in Chronic Obstructive Pulmonary Disease (COPD) Patients Managed with Aerobika OPEP | Pulmonary Therapy | 2017 | 11 |
| 46 | Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis: Experience from 92 Sites in an Open-Label US Expanded Access Program | Pulmonary Therapy | 2017 | 11 |
| 47 | Procalcitonin for Antibiotic Prescription in Chronic Obstructive Pulmonary Disease Exacerbations: Systematic Review, Meta-Analysis, and Clinical Perspective | Pulmonary Therapy | 2020 | 11 |
| 48 | CFTR Modulator Therapy and Its Impact on Lung Transplantation in Cystic Fibrosis | Pulmonary Therapy | 2021 | 11 |
| 49 | Phage Therapy for Nontuberculous Mycobacteria: Challenges and Opportunities | Pulmonary Therapy | 2023 | 11 |
| 50 | Validation of a New Portable Exhaled Nitric Oxide Analyzer, NIOX VERO®: Randomized Studies in Asthma | Pulmonary Therapy | 2017 | 10 |
